SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-21-006045
Filing Date
2021-02-24
Accepted
2021-02-24 17:16:40
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B5 nt10020784x3_424b5.htm 424B5 863563
2 logo_inflarx.jpg GRAPHIC 27642
3 nt10020784x3_barchart01.jpg GRAPHIC 138001
4 nt10020784x3_barchart02.jpg GRAPHIC 168415
5 nt10020784x3_flowchart01.jpg GRAPHIC 103598
6 nt10020784x3_formula1.jpg GRAPHIC 16110
7 nt10020784x3_fraction01.jpg GRAPHIC 15936
8 nt10020784x3_linechart01.jpg GRAPHIC 153118
9 nt10020784x3_linechart02.jpg GRAPHIC 179819
10 nt10020784x3_linechart03.jpg GRAPHIC 159599
  Complete submission text file 0001140361-21-006045.txt   2188256
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-239759 | Film No.: 21674828
SIC: 2834 Pharmaceutical Preparations